481-49-2 Usage
Uses
Used in Pharmaceutical Applications:
Cepharanthine is used as a therapeutic agent for various acute and chronic diseases, including pit viper bites, alopecia areata, and leucopenia in radiation therapy. It is particularly effective in treating lung diseases, as it was initially used to treat tuberculosis and other consumptive diseases.
Used in Anticancer Applications:
Cepharanthine is employed as an antineoplastic agent, stimulating the recovery of immunologic function in the lymphatic system after the administration of antineoplastic agents or x-irradiation. It is a member of isoquinolines and a bisbenzylisoquinoline alkaloid, contributing to its effectiveness in cancer treatment.
Used in Inflammation and Immune System Support:
Cepharanthine is used as an anti-inflammatory agent, helping to reduce inflammation and support the immune system. Its hepatoprotectant properties also aid in liver protection and recovery.
Used in Radioprotective Applications:
Cepharanthine serves as a radioprotective agent, providing protection against the harmful effects of radiation exposure, particularly in the context of radiation therapy for cancer patients.
History
Promoting leukocytosis of cepharanthine in tuberculosis patients was first recorded in the proceeding Institute of Chemotherapy by the Japanese scholar Yamaguchi in 1946. In 1948, Chinese scholar Yuhuang Zhao also received this compound and published it in D.M.?Med.It is thought that cepharanthine may stimulate the reticuloendothelial system, then activate hematopoietic tissue, and promote myeloproliferation. Therefore, the number of white blood cells in the peripheral blood increased significantly. Due to its good safety, cepharanthine is currently widely used in cancer patients with granulocytopenia or leukopenia embolism after radiotherapy and chemotherapy and so on.In addition, Chinese scientists extracted five kinds of dibenzylisoquinoline alkaloids from Chinese herbal medicine in 1977, which could significantly improve the
silicosis symptoms in rat . In 1993, it was issued as anti-pneumoconiosis drug by
CFDA and is used for delaying the progress of pneumoconiosis in clinic.
benefits
When Cepharanthine is absorbed into the body, it acts through multiple biochemical and pharmacological mechanisms and generates a tremendous amount of beneficial effects on one's health. Regrow hair in a number of patients with different types of alopeciaInhibit various types of cancerous tumor growthPrevent cancer metastasisStimulate white blood cell productionInduce apoptosis (cell death) and autophagy in cancerous cellsRestore the effectiveness of anticancer drugs for resistant tumorsBoost the effectiveness of certain chemotherapies Inhibit the replication of HIV-1 virusInhibit different types of CoronavirusProvide relief of allergies by inhibiting the release of histaminePossess anti-viral and anti-inflammatory effectsScavenge free radicals and prevent oxidation
Biological Activity
Cepharanthine, a biscoclaurine alkaloid isolated from a Chinese folklore plant Stephania cepharantha, inhibited HIV-1 replication by inhibiting kappa B, a potent inducer of HIV-1 gene expression and displayed potent activity against SARS coronavirus, HSV-1, and coxsackie B3 along with antitumor and immunomodulating activity. As cepharanthine had strong activity against both RNA and DNA viruses it may be a source of potential lead compounds for developing new antivirals.
Pharmacology
The pharmacological effects of cepharanthine are very broad, mainly for the promotion of leukocytosis, antitumor, anti-inflammation, improvement of the body immunity, and other aspects of efficacy. Improvement of leukocytosis is the most widely
studied among them, and the mechanism may be to stimulate the reticular endothelium system, activate hematopoietic tissue, and promote bone marrow hyperplasia .Cepharanthine is also a good antitumor drug sensitizer. It can significantly
improve their efficacy and reduce their side effects when combined with other antitumor drugs, as manifested by increasing the concentration of FT-207 metabolite
(5-Fu) in tumor tissue under cepharanthine and FT-207 combination therapy, which
was significantly higher than that in blood , suggesting that cepharanthine has the
potential to improve the efficacy of antitumor drugs.
Clinical Use
The major clinical application of cepharanthine is to improve their immunity impaired by chemotherapy or radiotherapy in tumor patients. In addition, cepharanthine can increase the sensitivity to antitumor drugs, and itself also has a certain antitumor effect. Now, it is commonly used as adjuvant drug for anticancer treatment.
Side effects
Cepharanthine is an extraordinary medicine from Japan, where it has been widely used for the past seventy years to treat a variety of acute and chronic diseases, with little known side-effects. Common side effects are reported as below. loss of appetite, disc omfort in stomach, rash/eruption, itch , nausea, diarrhea, headache, dizziness, swelling in face/hands/feet, irregular menstruation, etc.
References
Rogosnitzky and Dank (2011), Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions; Pharmacol. Rep., 63 337
Huang et al. (2014), Cepharanthine, an alkaloid from Stephania cepharantha Hayata inhibits the inflammatory response in the RAW264.7 cell and mouse models; Inflammation, 37 235
Wang et al. (2020), Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC); Expert Opin. Ther. Targets, 24 389
Zhang et al. (2019), Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network; J. Exp. Clin. Cancer Res. 38 457
Rosognitzky et al. (2020), Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19; Pharmacol. Rep., 72 1509
Check Digit Verification of cas no
The CAS Registry Mumber 481-49-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 4,8 and 1 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 481-49:
(5*4)+(4*8)+(3*1)+(2*4)+(1*9)=72
72 % 10 = 2
So 481-49-2 is a valid CAS Registry Number.
InChI:InChI=1/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3
481-49-2Relevant articles and documents
Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea
Lv, Jun-Jiang,Xu, Min,Wang, Dong,Zhu, Hong-Tao,Yang, Chong-Ren,Wang, Yi-Fei,Li, Yan,Zhang, Ying-Jun
, p. 926 - 932 (2013)
Six new bisbenzylisoquinoline alkaloids (1-6) and seven known compounds (8-14) were isolated from the tubers of Stephania epigaea, in addition to the major alkaloid, cepharanthine (7). The structures of 1-6 were elucidated by combined spectroscopic data analysis and chemical methods, with their configurations determined from their optical rotation values and confirmed using circular dichroism. Compounds 1-6 belong to the oxyacanthine type of bisbenzylisoquinoline alkaloids and have a rare methylenedioxy substituent. Compound 1, a dimer composed of benzylisoquinoline and seco-aristolactam units, represents a new type of bisbenzylisoquinoline alkaloid, while compounds 3-6 are bisbenzylisoquinoline N-oxides. These compounds were evaluated for their in vitro cytotoxicities against six human cancer cell lines (A-549, ECA109, HL-60, MCF-7, SMMC-7721, and SW480). Cepharanthine (7), the major component of S. epigaea, exhibited cytotoxicity against all of these cancer cell lines except ECA109, while its known analogue, 10, displayed cytotoxicity against all six cancer cell lines.
Compounds and compositions for treating infection
-
, (2009/04/24)
Compounds from 14 Kenyan plants, including from the root of Dovyalis abyssinica and Clutia robusta have been characterized and isolated, and their uses are disclosed.